Chemomab Therapeutics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 80.00 K | $125.60 K | 0.00% | 1.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 64.18 K | $100.77 K | -38.16% | 0.80% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 04/20/2026 | 61.71 K | $96.89 K | 19.34% | 0.77% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 51.79 K | $81.32 K | 0.00% | 0.65% |
| XTX TOPCO LTD | 05/15/2026 | 18.63 K | $29.25 K | -2.02% | 0.23% |
| RHUMBLINE ADVISERS | 05/12/2026 | 18.37 K | $28.83 K | 2.86% | 0.23% |
| 04/21/2026 | 14.57 K | $22.87 K | 100.00% | 0.18% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 13.49 K | $21.18 K | 100.00% | 0.17% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 8.43 K | $13.23 K | 3.69% | 0.11% |
| 05/05/2026 | 8.20 K | $12.87 K | 100.00% | 0.10% | |
| GAMMA INVESTING LLC | 04/06/2026 | 7.58 K | $11.90 K | 201.47% | 0.10% |
| MORGAN STANLEY | 05/15/2026 | 4.58 K | $7.18 K | 21.19% | 0.06% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 28 | $44 | 7.69% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 8 | $13 | -99.64% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 8 | $13 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Chemomab Therapeutics Ltd institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Chemomab Therapeutics Ltd. The most heavily invested institutionals were:
ADAR1 Capital Management, LLC: 80,000
CITADEL ADVISORS LLC: 64,182
KESTRA PRIVATE WEALTH SERVICES, LLC: 61,710
Ikarian Capital, LLC: 51,793
XTX Topco Ltd: 18,629
RHUMBLINE ADVISERS: 18,366
4.41% of Chemomab Therapeutics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 354.88 K shares in the last 24 months. This purchase volume represents approximately $709.76 K in transactions.